US Prescription trends of antihistamines for atopic dermatitis, 2011‐2016
- 27 November 2020
- journal article
- research article
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (1) , 324-326
Abstract
Antihistamine use for primary treatment of atopic dermatitis (AD) is not recommended, but current guidelines state that sedating antihistamines are favored over non‐sedating antihistamines for relief of burdensome pruritus. We analyzed the National Ambulatory Medical Care Survey data to compare use of antihistamines between dermatologists and non‐dermatologists. Overall, dermatologists are more likely to prescribe sedating than non‐sedating antihistamines when compared to non‐dermatologists (P < .001, δabs = 0.45). Patients under 21 years old (P = .03, δabs = 0.10) and Black patients (P < .001, δabs = 0.19) were also more likely to receive sedating antihistamines than non‐sedating antihistamines. These findings highlight the differential prescribing practices for atopic dermatitis among physicians.Keywords
This publication has 4 references indexed in Scilit:
- An assessment of the use of antihistamines in the management of atopic dermatitisJournal of the American Academy of Dermatology, 2018
- Guidelines of care for the management of atopic dermatitisJournal of the American Academy of Dermatology, 2014
- Nocturnal Itch: Why Do We Itch At Night?Acta Dermato-Venereologica, 2007
- Treatment of Atopic Dermatitis and Impact on Quality of LifePharmacoEconomics, 2003